PDCD1 and neoplasm: The use of ICI mAbs to prevent the interaction between PD-1 and its ligands on the surface of T cells contributed to the inhibition of neoplastic growth by reviving the cytotoxic functions of CTLs against tumor antigens, a process caused by the PD-1/PD-L1 induced immunosuppression [134] (Figure 2).